B of A Securities analyst Sara Senatore initiates coverage on Papa John's International (NASDAQ:PZZA) with a Buy rating and announces Price Target of $103.
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that its Board of Directors (the "Board") has